Oropharyngeal Vs Intravenous Lidocaine Effects on Optic Nerve Sheath Diameter After Intubation
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-65
SponsorAnkara City Hospital Bilkent
About this trial
This study aims to evaluate the effects of pre-intubation oropharyngeal topical lidocaine on optic nerve sheath diameter (ONSD) post-endotracheal intubation. The study will measure the ONSD using ultrasonography before intubation, and at 1, 5, and 10 minutes post-intubation. The results will be compared between patients receiving %10 lidocaine topically and %2 intravenous lidocaine.
Eligibility criteria
Qualifiers
ASA class I or II
Age 18-65 years
BMI 18-30
No history or expected difficult intubation
Disqualifiers
ASA class III and above
Obesity (BMI > 30)
Difficult intubation history or risk
Glaucoma or other ophthalmic pathology
Trial design
Treatments tested in this trial
- Optic nerve sheath diameter measurement 0
- optic nerve sheath diameter measurement 1
- optic nerve sheath diameter measurement 2
- optic nerve sheath diameter measurement 3
- Pre-intubation oropharyngeal topical %10 lidocaine
- Pre-intubation intravenous %2 lidocaine
Treatment groups
190 Participants
are divided into 2 treatment groupsLocations
1Ankara Bilkent City Hospital06800, AnkaraTurkey, Turkey (Türkiye)
Sponsors and collaborators
Ankara City Hospital Bilkent
Lead sponsor
Source ClinicalTrials.gov